• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV-2 infection and the antiviral innate immune response.

作者信息

Yang Hui, Lyu Yingying, Hou Fajian

机构信息

Department of Neurosurgery, Huashan Hospital, Institute for Translational Brain Research, MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.

Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200032, China.

出版信息

J Mol Cell Biol. 2020 Nov 26;12(12):963-967. doi: 10.1093/jmcb/mjaa071.

DOI:10.1093/jmcb/mjaa071
PMID:33377937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7798998/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/7948080/d676b4fbdf67/mjaa071f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/7948080/767b4c08cd38/mjaa071f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/7948080/a4d1c91611cc/mjaa071f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/7948080/d676b4fbdf67/mjaa071f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/7948080/767b4c08cd38/mjaa071f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/7948080/a4d1c91611cc/mjaa071f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/7948080/d676b4fbdf67/mjaa071f3.jpg

相似文献

1
SARS-CoV-2 infection and the antiviral innate immune response.严重急性呼吸综合征冠状病毒2型感染与抗病毒固有免疫反应
J Mol Cell Biol. 2020 Nov 26;12(12):963-967. doi: 10.1093/jmcb/mjaa071.
2
Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.从 COVID-19 患者的鼻咽样本中进行转录组分析，并与其他 SARS-CoV-2 感染模型进行比较分析，揭示了宿主针对 SARS-CoV-2 的不同反应。
J Transl Med. 2021 Jan 7;19(1):32. doi: 10.1186/s12967-020-02695-0.
3
SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.严重急性呼吸综合征冠状病毒2变体与康复期血浆：现实、谬误与机遇
J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI148832.
4
Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.病毒导致 COVID-19 中 I 型干扰素反应和炎症失衡。
Front Immunol. 2021 Apr 12;12:633769. doi: 10.3389/fimmu.2021.633769. eCollection 2021.
5
An Update on Innate Immune Responses during SARS-CoV-2 Infection.关于 SARS-CoV-2 感染期间固有免疫反应的最新研究进展。
Viruses. 2021 Oct 14;13(10):2060. doi: 10.3390/v13102060.
6
Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2.严重急性呼吸综合征冠状病毒 2 型对 I 型干扰素的拮抗作用。
J Interferon Cytokine Res. 2020 Dec;40(12):543-548. doi: 10.1089/jir.2020.0214.
7
COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.COVID19 疾病图谱，一个病毒 - 宿主相互作用机制的计算知识库。
Mol Syst Biol. 2021 Oct;17(10):e10387. doi: 10.15252/msb.202110387.
8
Long Noncoding RNAs as Emerging Regulators of COVID-19.长链非编码 RNA 作为 COVID-19 的新兴调控因子。
Front Immunol. 2021 Aug 2;12:700184. doi: 10.3389/fimmu.2021.700184. eCollection 2021.
9
Virus-, host-, immune-based targets for COVID-19 therapy.用于COVID-19治疗的基于病毒、宿主和免疫的靶点。
Drug Discov Today. 2020 Dec;25(12):2071-2073. doi: 10.1016/j.drudis.2020.10.001. Epub 2020 Oct 6.
10
Compartmental Model Suggests Importance of Innate Immune Response to COVID-19 Infection in Rhesus Macaques. compartmental model compartmental 模型 suggests 表明 importance 重要性 innate immune response 先天免疫应答 COVID-19 感染 rhesus macaques 恒河猴
Bull Math Biol. 2021 May 26;83(7):79. doi: 10.1007/s11538-021-00909-0.

引用本文的文献

1
The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）BQ.1.1和XBB.1.16谱系中的NSP6-L260F替代可弥补由NSP13和NSP14突变导致的病毒聚合酶活性降低。
J Virol. 2025 Jun 17;99(6):e0065625. doi: 10.1128/jvi.00656-25. Epub 2025 May 13.
2
Naringenin Improves Innate Immune Suppression after PRRSV Infection by Reactivating the RIG-I-MAVS Signaling Pathway, Promoting the Production of IFN-I.柚皮素通过激活 RIG-I-MAVS 信号通路，促进 IFN-I 的产生，改善 PRRSV 感染后的固有免疫抑制。
Viruses. 2023 Oct 29;15(11):2172. doi: 10.3390/v15112172.
3

本文引用的文献

1
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19.一项关于氯喹治疗COVID-19安全性和有效性的多中心前瞻性观察性研究的初步证据。
Natl Sci Rev. 2020 May 28;7(9):1428-1436. doi: 10.1093/nsr/nwaa113. eCollection 2020 Sep.
2
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.瑞德西韦对比标准治疗对 11 天内中症 COVID-19 患者临床状态的影响：一项随机临床试验。
JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349.
3
Cytoskeleton-a crucial key in host cell for coronavirus infection.
SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks".
SARS-CoV-2 与先天免疫：好、坏与“恰到好处”。
Cell Mol Immunol. 2024 Feb;21(2):171-183. doi: 10.1038/s41423-023-01104-y. Epub 2023 Nov 20.
4
The multiple roles of nsp6 in the molecular pathogenesis of SARS-CoV-2.nsp6 在 SARS-CoV-2 分子发病机制中的多重作用。
Antiviral Res. 2023 May;213:105590. doi: 10.1016/j.antiviral.2023.105590. Epub 2023 Mar 31.
5
The multi-functional roles of the cGAS-STING signaling pathway in health and diseases.cGAS-STING信号通路在健康与疾病中的多功能作用。
J Mol Cell Biol. 2023 Feb 7;14(9). doi: 10.1093/jmcb/mjac057.
6
Molecular Function of cGAS-STING in SARS-CoV-2: A Novel Approach to COVID-19 Treatment.cGAS-STING 在 SARS-CoV-2 中的分子功能：COVID-19 治疗的新方法。
Biomed Res Int. 2022 Nov 22;2022:6189254. doi: 10.1155/2022/6189254. eCollection 2022.
7
Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2.病毒-宿主相互作用网络作为 IAV 和 SARS-CoV-2 的新型抗病毒药物靶点。
Emerg Microbes Infect. 2022 Dec;11(1):1371-1389. doi: 10.1080/22221751.2022.2071175.
8
Can help control cytokine storm in COVID-19?能否有助于控制新冠病毒疾病中的细胞因子风暴？
J Ginseng Res. 2022 May;46(3):337-347. doi: 10.1016/j.jgr.2022.02.006. Epub 2022 Feb 25.
9
NF-κB signaling in inflammation and cancer.炎症与癌症中的核因子-κB信号传导
MedComm (2020). 2021 Dec 16;2(4):618-653. doi: 10.1002/mco2.104. eCollection 2021 Dec.
10
Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection.癌症患者中导致 SARS-CoV-2 感染不良结局的免疫机制。
Transl Res. 2022 Mar;241:83-95. doi: 10.1016/j.trsl.2021.12.001. Epub 2021 Dec 3.
细胞骨架——冠状病毒感染宿主细胞的关键钥匙。
J Mol Cell Biol. 2020 Jul 1;12(12):968-979. doi: 10.1093/jmcb/mjaa042.
4
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients.回顾性多中心队列研究表明，早期干扰素治疗与 COVID-19 患者的良好临床反应相关。
Cell Host Microbe. 2020 Sep 9;28(3):455-464.e2. doi: 10.1016/j.chom.2020.07.005. Epub 2020 Jul 18.
5
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.羟氯喹或联合阿奇霉素治疗轻中度 COVID-19。
N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23.
6
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.羟氯喹在非人类灵长类动物中对抗 SARS-CoV-2 感染的应用。
Nature. 2020 Sep;585(7826):584-587. doi: 10.1038/s41586-020-2558-4. Epub 2020 Jul 22.
7
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.氯喹不能抑制 SARS-CoV-2 感染人肺细胞。
Nature. 2020 Sep;585(7826):588-590. doi: 10.1038/s41586-020-2575-3. Epub 2020 Jul 22.
8
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.严重 COVID-19 患者的 I 型干扰素活性和炎症反应受损。
Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13.
9
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.COVID-19 和流感的免疫表型分析突出了 I 型干扰素在 COVID-19 重症发展中的作用。
Sci Immunol. 2020 Jul 10;5(49). doi: 10.1126/sciimmunol.abd1554.
10
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.